Last $133.69 USD
Change Today +3.24 / 2.48%
Volume 7.4M
AMGN On Other Exchanges
Symbol
Exchange
Hong Kong
Mexico
NASDAQ GS
Sao Paulo
Frankfurt
As of 8:10 PM 10/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger M. Perlmutter M.D., Ph.D.

Former Consultant, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 37 board members in 2 different organizations across 8 different industries.

See Board Relationships
62$5,986,124

Background*

Dr. Roger M. Perlmutter, M.D., Ph.D. has been the Executive Vice President and President of Merck Research Laboratories at Merck & Co. Inc. since April 15, 2013. Dr. Perlmutter serves as Science Partner at The Column Group LLC. Dr. Perlmutter was a Professor in the Departments of Immunology, Biochemistry and Medicine at the University of Washington in Seattle from January 1991 to January 1997. From 1981 to 1984, he was a Lecturer in the Division of Biology at the California ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*

Director
2000-2013
Former Director and Member of Corporate Governance & Nominating Committee
2012-2013
Former Director
2012-Present
Non-Executive Director
2012-N/A
Former Director and Member of Scientific Advisory Board

Education*

Unknown/Other Education 1973
Reed College
PhD 1979
Washington University, St. Louis
MD 1979
Washington University, St. Louis

Other Affiliations*

Annual Compensation*

Salary$711,538
Bonus$500,000
Total Annual Compensation$1,211,538

Stock Options*

Restricted Stock Awards$2,699,987
All Other Compensation$16,459
Unexercisable Options225,443
Unexercisable Options Value$1,142,996
Total Value of Options$1,142,996
Total Number of Options225,443

Total Compensation*

Total Annual Cash Compensation$1,851,697
Total Short Term Compensation$1,211,538
Other Long Term Compensation$2,716,446
Total Calculated Compensation$5,986,124
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMGN:US $133.69 USD +3.24

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.